Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc.
Shasqi, Inc.
Tempus AI
Actym Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Elevation Oncology
Aminex Therapeutics, Inc.
Merck Sharp & Dohme LLC
Pfizer
CytomX Therapeutics
Fate Therapeutics
Fate Therapeutics
Hoffmann-La Roche
University of Iowa
Advaxis, Inc.
Rubius Therapeutics
Tocagen Inc.
CureOne
University Health Network, Toronto
Vanderbilt-Ingram Cancer Center